InvestorsHub Logo

moonotaur

11/26/19 8:46 PM

#230387 RE: Retire2019 #230385

It doesn’t really matter at that point. The labeling is the de-risking event. Regardless of when the info is released, the stock will start trading with the FDA certainty behind it and should revert to fair value.

Atom0aks

11/26/19 8:49 PM

#230389 RE: Retire2019 #230385

Hypothetically if Amrn received approval today or tomorrow, wouldn’t they. E wise to sit on it until Monday for a premarket release to maximize the impact since markets will be very slow tomorrow and Friday?



I don't think the stock market has any say in what the FDA does or says. Regardless of what Amarin does, I think the FDA will still post the results here,

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process

Bio_pete

11/26/19 8:55 PM

#230390 RE: Retire2019 #230385

"Hypothetically if Amrn received approval today or tomorrow, wouldn’t they. E wise to sit on it until Monday"

No, drug approvals are released to the public the following day if not sooner by the FDA. Just look at GBT. It's drug approval yesterday is already on the FDA website.